A fully integrated endotoxin testing system that delivers best-in-class sensitivity using a fraction of FDA-licensed turbidimetric LAL reagent. Using CMD's revolutionary sensing technology, quantitative results are provided in as little as 5 minutes with minimal user input needed beyond introduction of sample. The on-board FDA 21 CFR Part 11 ready software package ensures data integrity, allowing users to perform Pharmacopoeial compliant tests.

With recurring costs typically 1/3rd of other cartridge-based testing systems, the αBET™ system provides a cost-effective solution to in-process and final product testing across pharmaceutical manufacturing sites, quality control laboratories as well as in research and development facilities.

• Rapid, sustainable and compliant endotoxin testing
• Quantitative results delivered in a matter of minutes
• Uses less than 10% of the reagent volume of traditional tests
• System walks users through performing a pharmacopoeial compliant assay, whilst also allowing for flexible sample analysis
• On-board FDA part 11 ready software ensures data integrity